Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Tolterodine: Pipeline™ Selector' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Tolterodine Pipeline Developer |
Ongoing | £2925 | 100 % |
|
Tolterodine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 | 96 % |
|
Tolterodine: Core Country Coverage Pipeline Selector |
Ongoing | £260 | 96 % |
|
Urinary Incontinence - Lifecycle Management Strategies Retain Mid-Term Market Growth Pipeline And Commercial Insight |
December 2007 | £7600 | 35 % |
|
Dry Overactive Bladder A Precursor to 'Wet Overactive Bladder'? |
April 2006 | £2170 | 26.5 % |
|
Pfizer Pipeline ,Products ,Performance ,Potential |
June 2008 | £595 | 25.55 % |
|
Urge Urinary Incontinence Poor Differentiation Limiting New Product Uptake |
April 2006 | £8690 | 25.5 % |
|
Management of Urinary Incontinence and Overactive Bladder A Global Overview |
June 2006 | £8695 | 20.65 % |
|
The Overactive Bladder: Evaluation and Management |
June 2007 | £125 | 20.3 % |
|
Handbook of Pharmaceutical Manufacturing Formulations - Vol 2 of 6 Uncompressed Solid Products |
April 2007 | £195 | 5.6 % |
|
Handbook of Pharmaceutical Manufacturing Formulations - Vol 1 of 6 Compressed Solid Products |
April 2007 | £195 | 4.55 % |
